Iowa City, IA, United States of America

James B Martins

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Zealand Pharma A/s. Active years: 2009-2010.



Average Co-Inventor Count = 8.5

ph-index = 1

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2009-2010

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by James B Martins

Introduction

James B Martins is a notable inventor based in Iowa City, IA (US). He has made significant contributions to the field of medical science, particularly through his innovative work on peptides. With a total of 2 patents, his research focuses on improving the stability and efficacy of antiarrhythmic peptides.

Latest Patents

Martins' latest patents include groundbreaking discoveries in the realm of antiarrhythmic peptides. These novel peptides are designed to have improved stability, which is crucial for their effectiveness as medicaments. Additionally, he has developed compositions that incorporate these peptides, along with methods for their use in medical applications. Another significant patent involves the medical uses of intercellular communication facilitating compounds, further showcasing his expertise in peptide technology.

Career Highlights

James B Martins is currently associated with Zealand Pharma A/S, where he continues to push the boundaries of peptide research. His work has the potential to lead to advancements in treatments for various medical conditions, particularly those related to heart health.

Collaborations

Some of his notable coworkers include Bjarne Due Larsen and Eddi Meier, who contribute to the collaborative environment that fosters innovation at Zealand Pharma A/S.

Conclusion

James B Martins exemplifies the spirit of innovation in the medical field through his research and patents. His contributions are paving the way for new therapeutic options that could significantly impact patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…